• Learning Objective 1: Appreciate the variety of psychiatric presentations after levetiracetam treatment
  • Learning Objective 2: Recognize benefits, risks and alternatives to levetiracetam treatment
Session date: 
Thursday, April 18, 2019 - 12:00pm to 1:30pm
Speaker Name: 
Oday Alsarraf, M.D., Ph.D.
Location: 
UCMC / H 103
5841 S. Maryland Ave.
Chicago, IL 60637
United States
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Please login or create an account to proceed.